These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31202993)

  • 1. Identify liver X receptor β modulator building blocks by developing a fluorescence polarization-based competition assay.
    Zhang Z; Chen H; Chen Z; Ding P; Ju Y; Gu Q; Xu J; Zhou H
    Eur J Med Chem; 2019 Sep; 178():458-467. PubMed ID: 31202993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Tetrachlorophthalimides as Liver X Receptor β (LXRβ)-Selective Agonists.
    Nomura S; Endo-Umeda K; Makishima M; Hashimoto Y; Ishikawa M
    ChemMedChem; 2016 Oct; 11(20):2347-2360. PubMed ID: 27690261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, structure activity relationships and X-Ray co-crystallography of non-steroidal LXR agonists.
    Bennett DJ; Carswell EL; Cooke AJ; Edwards AS; Nimz O
    Curr Med Chem; 2008; 15(2):195-209. PubMed ID: 18220775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of new LXRβ agonists as glioblastoma inhibitors.
    Chen H; Chen Z; Zhang Z; Li Y; Zhang S; Jiang F; Wei J; Ding P; Zhou H; Gu Q; Xu J
    Eur J Med Chem; 2020 May; 194():112240. PubMed ID: 32248003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of crystal structures of LXRbeta in relation to plasticity of the ligand-binding domain upon ligand binding.
    Malini N; Rajesh H; Berwal P; Phukan S; Balaji VN
    Chem Biol Drug Des; 2008 Feb; 71(2):140-54. PubMed ID: 18221307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The important role of residue F268 in ligand binding by LXRbeta.
    Urban F; Cavazos G; Dunbar J; Tan B; Escher P; Tafuri S; Wang M
    FEBS Lett; 2000 Nov; 484(2):159-63. PubMed ID: 11068052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyodeoxycholic acid derivatives as liver X receptor α and G-protein-coupled bile acid receptor agonists.
    De Marino S; Carino A; Masullo D; Finamore C; Marchianò S; Cipriani S; Di Leva FS; Catalanotti B; Novellino E; Limongelli V; Fiorucci S; Zampella A
    Sci Rep; 2017 Feb; 7():43290. PubMed ID: 28233865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based virtual screening for identification of potential non-steroidal LXR modulators against neurodegenerative conditions.
    Deshwal S; Baidya AT; Kumar R; Sandhir R
    J Steroid Biochem Mol Biol; 2022 Oct; 223():106150. PubMed ID: 35787453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and activity evaluation of a series of cholanamides as modulators of the liver X receptors.
    Martínez MD; Ghini AA; Dansey MV; Veleiro AS; Pecci A; Alvarez LD; Burton G
    Bioorg Med Chem; 2018 Mar; 26(5):1092-1101. PubMed ID: 29428525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structurally Selective Mechanism of Liver X Receptor Ligand:
    Ding P; Chen Z; Chen H; Zhang Z; Liu Z; Yan X; Zhou H; Gu Q; Li C; Xu J
    J Chem Inf Model; 2019 Jul; 59(7):3277-3290. PubMed ID: 31192592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C24-hydroxylated stigmastane derivatives as Liver X Receptor agonists.
    Castro Navas FF; Giorgi G; Maggioni D; Pacciarini M; Russo V; Marinozzi M
    Chem Phys Lipids; 2018 May; 212():44-50. PubMed ID: 29352964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A de novo substructure generation algorithm for identifying the privileged chemical fragments of liver X receptorβ agonists.
    Peng H; Liu Z; Yan X; Ren J; Xu J
    Sci Rep; 2017 Sep; 7(1):11121. PubMed ID: 28894088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identfication of Potent LXRβ-Selective Agonists without LXRα Activation by In Silico Approaches.
    Chen M; Yang F; Kang J; Gan H; Yang X; Lai X; Gao Y
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29867043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist.
    Zheng Y; Zhuang L; Fan KY; Tice CM; Zhao W; Dong C; Lotesta SD; Leftheris K; Lindblom PR; Liu Z; Shimada J; Noto PB; Meng S; Hardy A; Howard L; Krosky P; Guo J; Lipinski K; Kandpal G; Bukhtiyarov Y; Zhao Y; Lala D; Van Orden R; Zhou J; Chen G; Wu Z; McKeever BM; McGeehan GM; Gregg RE; Claremon DA; Singh SB
    J Med Chem; 2016 Apr; 59(7):3264-71. PubMed ID: 26990539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel liver X receptor activators by structure-based modeling.
    von Grafenstein S; Mihaly-Bison J; Wolber G; Bochkov VN; Liedl KR; Schuster D
    J Chem Inf Model; 2012 May; 52(5):1391-400. PubMed ID: 22489742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional pharmacophore modeling of liver-X receptor agonists.
    Zhao W; Gu Q; Wang L; Ge H; Li J; Xu J
    J Chem Inf Model; 2011 Sep; 51(9):2147-55. PubMed ID: 21434646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of a high-affinity fluorescent PPARgamma ligand for high-throughput fluorescence polarization assays.
    DeGrazia MJ; Thompson J; Heuvel JP; Peterson BR
    Bioorg Med Chem; 2003 Oct; 11(20):4325-32. PubMed ID: 13129568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of phthalimide-based fluorescent liver x receptor antagonists.
    Kishida K; Aoyama A; Hashimoto Y; Miyachi H
    Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1525-8. PubMed ID: 21048348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorinated oxysterol analogues: Synthesis, molecular modelling and LXRβ activity.
    Rodriguez CR; Alvarez LD; Dansey MV; Paolo LS; Veleiro AS; Pecci A; Burton G
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):268-276. PubMed ID: 27452335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design and synthesis of fluorescent PPARalpha/delta co-agonist and its application as a probe for fluorescent polarization assay of PPARdelta ligands.
    Araya Y; Kasuga J; Toyota K; Hirakawa Y; Oyama T; Makishima M; Morikawa K; Hashimoto Y; Miyachi H
    Chem Pharm Bull (Tokyo); 2008 Sep; 56(9):1357-9. PubMed ID: 18758120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.